PFBT
ALXN

Parkside Financial Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-142
Closed -$26K – 1903
2021
Q2 		$26K Buy
142
+14
+11% +$2.4K 0.01% 699
2021
Q1 		$19K Buy
128
+2
+2% +$309 0.01% 785
2020
Q4 		$19K Buy
126
+17
+16% +$2.19K 0.01% 738
2020
Q3 		$13K Buy
109
+45
+70% +$4.86K ﹤0.01% 770
2020
Q2 		$7K Buy
64
+28
+78% +$2.97K ﹤0.01% 880
2020
Q1 		$3K Sell
36
-33
-48% -$3.24K ﹤0.01% 1055
2019
Q4 		$7K Buy
69
+32
+86% +$3.42K ﹤0.01% 882
2019
Q3 		$4K Sell
37
-33
-47% -$3.72K ﹤0.01% 1024
2019
Q2 		$9K Sell
70
-25
-26% -$3.22K ﹤0.01% 836
2019
Q1 		$13K Buy
95
+56
+144% +$6.96K ﹤0.01% 725
2018
Q4 		$4K Sell
39
-77
-66% -$9.1K ﹤0.01% 961
2018
Q3 		$17K Buy
116
+1
+0.9% +$125 0.01% 658
2018
Q2 		$14K Sell
115
-4
-3% -$467 0.01% 686
2018
Q1 		$13K Buy
119
+19
+19% +$2.27K ﹤0.01% 681
2017
Q4 		$12K Buy
100
+9
+10% +$1.1K ﹤0.01% 699
2017
Q3 		$13K Buy
91
+20
+28% +$2.72K 0.01% 670
2017
Q2 		$8K Sell
71
-42
-37% -$4.89K ﹤0.01% 799
2017
Q1 		$13K Buy
113
+47
+71% +$6.06K 0.01% 642
2016
Q4 		$8K Sell
66
-31
-32% -$3.79K ﹤0.01% 760
2016
Q3 		$12K Buy
97
+92
+1,840% +$11.8K 0.01% 687
2016
Q2 		$1K Sell
5
-7
-58% -$993 ﹤0.01% 1030
2016
Q1 		$2K Sell
12
-21
-64% -$3.08K ﹤0.01% 938
2015
Q4 		$6K Buy
33
+8
+32% +$1.4K ﹤0.01% 757
2015
Q3 		$4K Buy
+25
New +$4.56K ﹤0.01% 825

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Parkside Financial Bank & Trust's ALXN Position: Q3 2021 in Review

Parkside Financial Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 142 shares — an estimated $26K sold.

Parkside Financial Bank & Trust first reported a position in ALXN in Q3 2015 and held it in 24 quarters. The position peaked at $26K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Parkside Financial Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 142 Alexion Pharmaceuticals shares in Q3 2021, an estimated $26K.
  • Parkside Financial Bank & Trust first reported a position in Alexion Pharmaceuticals in Q3 2015 and held it in 24 quarters.
  • Parkside Financial Bank & Trust's Alexion Pharmaceuticals position peaked at $26K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2021, filed 29 Oct 2021.